Thrombovascular events in systemic lupus erythematosus: comment on the article by Jung et al

被引:1
|
作者
Wallace, Daniel J. [1 ]
机构
[1] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源
ARTHRITIS AND RHEUMATISM | 2010年 / 62卷 / 09期
关键词
D O I
10.1002/art.27621
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2824 / 2824
页数:1
相关论文
共 50 条
  • [21] Systemic lupus erythematosus and atherosclerosis progression risk: comment on the article by Papazoglou et al.
    Sener, Yusuf Ziya
    Sener, Seher
    ARTHRITIS & RHEUMATOLOGY, 2025,
  • [22] Treatment algorithms for patients with systemic lupus erythematosus: comment on the article by Muangchan et al Reply
    Muangchan, Chayawee
    Pope, Janet E.
    ARTHRITIS CARE & RESEARCH, 2016, 68 (09) : 1385 - 1386
  • [23] Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: comment on the article by Efthimiou et al
    Zhang, Hong-Liang
    Qin, Gui-Xiang
    Fan, Zhen-Yi
    Wu, Jiang
    ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 309 - 309
  • [24] APRIL in systemic lupus erythematosus: essential or dispensable? Comment on the article by Jacob et al Reply
    Jacob, Chaim O.
    Stohl, William
    ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2053 - 2054
  • [25] Refining research on systemic lupus erythematosus with key considerations: comment on the article by Xing et al
    Zhou, Qing
    ARTHRITIS & RHEUMATOLOGY, 2025, 77 (01) : 117 - 117
  • [26] The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al
    Major, Gabor A. C.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (04): : 1157 - 1158
  • [27] Galectin 9: Friend or Foe of Systemic Lupus Erythematosus? Comment on the Article by Zeggar et al
    Xu, Wang-Dong
    Su, Lin-Chong
    Huang, An-Fang
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (05) : 832 - 832
  • [28] Hydroxychloroquine dose after hospitalization for systemic lupus erythematosus: comment on the article by Nestor et al
    Sulu, Bercemhan
    Tascilar, Koray
    ARTHRITIS & RHEUMATOLOGY, 2025,
  • [29] New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: comment on the article by Ichikawa et al
    Ma, Yan
    Xu, Wang-Dong
    Pan, Hai-Feng
    Ye, Dong-Qing
    ARTHRITIS AND RHEUMATISM, 2012, 64 (04): : 1302 - 1302
  • [30] Association of Autoantibody Quantification With Systemic Lupus Erythematosus Disease Activity: Comment on the Article by Kim et al
    Tang, Xiaojun
    Ning, Mingzhe
    Zhu, Yantong
    Zhu, Yun
    Xu, Yang
    Wu, Si
    Feng, Xuebing
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (09) : 1588 - 1590